Target: A post approval study to evaluate targeted SCS (DRG) stimulation for the management of moderate to severe chronic, intractable, pain of the lower limbs due to CRPS types I and II,
Role: Investigator,
St. Jude Medical Inc.,
(08/2021 - 08/2022)
Status: Completed